• ChoiYoon YoungYYDepartment of Surgery, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Republic of Korea., Ji Yeong An, Hyung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, and Sung Hoon Noh.
• Department of Surgery, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Republic of Korea.
• Chin. Med. J. 2014 Jan 1; 127 (3): 547-53.

ObjectiveThe aim of this review was to overview the current practice of gastric cancer treatment including surgery and other adjuvant modalities.Data SourcesThe review was based on data obtained from the published articles and main guidelines in the East and West.Study SelectionArticles with high level of evidence or current best evidence in each issue were selected to be reviewed.ResultsAlthough varied adjuvant modalities have been proved to be benefit for treating gastric cancer, surgery is still the most important treatment strategy against gastric cancer. Actively adapting to new technology is important but it should be balanced with an effort to establish sound scientific rationale that adheres to oncologic principles.ConclusionsFuture treatment of gastric cancer will be focused on tailored, personalized therapy. For achieving it, collaboration across disciplines is essential. Also the philosophy of caring for the patients with gastric cancer should be rooted in the realization of true patient benefit regardless of who is providing the care. With these philosophies, we can shift the scientific and technological advances toward triumph over gastric cancer.

8 keywords...

hide…